Form D · Pharmaceuticals
Cold Genesys, Inc.
Santa Ana, CA · CIK 0001618677
Offering snapshot reported Jul 16, 2015 · SEC filing
- Reported sold
- Yet to sell Offering amount: $10M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $21.7K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 16, 2015 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Sep 23, 2014 | Initial | $3,569,704 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-243864
Source: Form D, filed Jul 16, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Phil Bendler | Director |
| Ronald Cheng | Director |
| Bernard Fung | Director |
| David Nikodem | Director |
| Arthur Przybyl | Director |
| Alex Yeung | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
6 Hutton Centre Drive Suite #1220
Santa Ana, CA, 92702
Santa Ana, CA, 92702